{
    "clinical_study": {
        "@rank": "8432", 
        "brief_summary": {
            "textblock": "PRIMARY: To determine the pharmacokinetics, MTD, and long-term safety and tolerance of oral\n      ganciclovir in HIV-infected infants, children, and adolescents.\n\n      SECONDARY: To evaluate the effect of oral ganciclovir on the virologic parameters of CMV.\n\n      Maintenance treatment with intravenous (IV) ganciclovir for cytomegalovirus retinitis in\n      AIDS patients is now standard therapy, but daily IV therapy can be complicated by catheter\n      infections and thrombosis. An oral regimen of ganciclovir has been administered safely in\n      adult AIDS patients and may be of significant benefit to children and infants as well."
        }, 
        "brief_title": "A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease", 
        "completion_date": {
            "#text": "March 1998", 
            "@type": "Actual"
        }, 
        "condition": [
            "Cytomegalovirus Infections", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Cytomegalovirus Infections"
            ]
        }, 
        "detailed_description": {
            "textblock": "Maintenance treatment with intravenous (IV) ganciclovir for cytomegalovirus retinitis in\n      AIDS patients is now standard therapy, but daily IV therapy can be complicated by catheter\n      infections and thrombosis. An oral regimen of ganciclovir has been administered safely in\n      adult AIDS patients and may be of significant benefit to children and infants as well.\n\n      Patients are assigned to 1 of 5 (PER AMENDMENT 10/24/95, was 4) oral (syrup or capsules)\n      dose levels following a single intravenous dose of ganciclovir. Treatment continues for 72\n      (PER AMENDMENT 10/24/95, was 24 weeks) weeks after the last patient has been enrolled."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        PER AMENDMENT 10/24/95: Allowed:\n\n          -  All antiretroviral agents and other medications except those listed under Exclusion -\n             Concurrent Medications.\n\n          -  Didanosine. However, patients receiving both drugs (didanosine and ganciclovir)\n             should be monitored for toxicity.\n\n          -  Amphotericin B is allowed but requires additional monitoring.\n\n        Patients must have:\n\n          -  HIV infection.\n\n          -  CMV infection.\n\n          -  CD4 count < 150 cells/mm3 or < 15 percent AND/OR quiescent CMV disease.\n\n          -  NO loss of sight from CMV retinitis.\n\n          -  NO acute opportunistic infection.\n\n          -  Life expectancy at least to study completion.\n\n          -  Consent of parent or guardian.\n\n        NOTE:\n\n          -  Infants < 6 months of age at enrollment must have been >= 36 weeks gestational age at\n             birth.\n\n        NOTE:\n\n          -  Patients may co-enroll in other ACTG protocols that do not involve the administration\n             of disallowed medications.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Loss of sight in one eye for any reason, with evidence of CMV retinitis in the other\n             eye.\n\n          -  Acute or chronic diarrhea that would affect absorption.\n\n          -  Clinical or laboratory toxicities of grade 3 or worse.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Foscarnet.\n\n          -  Acyclovir.\n\n          -  Interferon.\n\n          -  Myelotoxic agents for malignancy or other condition.\n\n          -  Other agents with anti-CMV activity. (NOTE:\n\n        Enrollment of patients on IVIG must be discussed with protocol chair.)\n\n          -  Imipenem/cilastatin sodium.\n\n        Prior Medication:\n\n        Excluded within 30 days prior to study entry:\n\n          -  G-CSF or GM-CSF."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "20 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "32", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000805", 
            "org_study_id": "ACTG 226", 
            "secondary_id": "11203"
        }, 
        "intervention": {
            "intervention_name": "Ganciclovir", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ganciclovir"
        }, 
        "keyword": [
            "Ganciclovir", 
            "Cytomegalovirus Infections", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "March 30, 2012", 
        "link": {
            "description": "Click here for more information about Ganciclovir", 
            "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=18"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90027"
                    }, 
                    "name": "Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Usc La Nichd Crs"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oakland", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94609"
                    }, 
                    "name": "Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92093"
                    }, 
                    "name": "UCSD Maternal, Child, and Adolescent HIV CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90502"
                    }, 
                    "name": "Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aurora", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "Univ. of Colorado Denver NICHD CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33161"
                    }, 
                    "name": "Univ. of Miami Ped. Perinatal HIV/AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60614"
                    }, 
                    "name": "Chicago Children's CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Tulane/LSU Maternal/Child CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "HMS - Children's Hosp. Boston, Div. of Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "BMC, Div. of Ped Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paterson", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "St. Joseph's Hosp. & Med. Ctr. of New Jersey"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia IMPAACT CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Incarnation Children's Ctr."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "NYU Med. Ctr., Dept. of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19134"
                    }, 
                    "name": "St. Christopher's Hosp. for Children"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "UW School of Medicine - CHRMC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Puerto Rico"
                    }, 
                    "name": "Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease", 
        "overall_official": [
            {
                "last_name": "Frenkel L", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Dankner W", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "reference": [
            {
                "citation": "Capparelli EV, Frenkel LM, Dankner W, Wei LJ, Xu J, Spector S, Connor J, Ballow A, Mohan K, Robinson C, Shaver A, Rich K, Thompson M, Read J, Wirkus C, Balsley J, Culnane M, Mcintosh K. Population pharmacokinetics of oral and intravenous ganciclovir (GCV) in HIV and CMV infected children. Program Abstr Intersci Conf Antimicrob Agents Chemother. 1996 Sep 15-18:10 (abstract no A51)"
            }, 
            {
                "citation": "Frenkel LM, Dankner W, Capparelli E, Wei LJ, Xu J, Spector S, Connor J, Ballow A, Mohan K, Robinson C, Shaver A, Rich K, Thompson M, Read J, Wirkus C, Balsley J, Culnane M, McIntosh K. A pharmacokinetic (PK) study of oral ganciclovir (GCV) in HIV- and cytomegalovirus (CMV)- infected children. Int Conf AIDS. 1996 Jul 7-12;11(2):31 (abstract no WeB550)"
            }, 
            {
                "PMID": "11069232", 
                "citation": "Frenkel LM, Capparelli EV, Dankner WM, Xu J, Smith IL, Ballow A, Culnane M, Read JS, Thompson M, Mohan KM, Shaver A, Robinson CA, Stempien MJ, Burchett SK, Melvin AJ, Borkowsky W, Petru A, Kovacs A, Yogev R, Goldsmith J, McFarland EJ, Spector SA. Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group. J Infect Dis. 2000 Dec;182(6):1616-24. Epub 2000 Nov 8."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000805"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "BMC, Div. of Ped Infectious Diseases": "42.358 -71.06", 
        "Chicago Children's CRS": "41.878 -87.63", 
        "Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.": "37.804 -122.271", 
        "Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy": "34.052 -118.244", 
        "Columbia IMPAACT CRS": "40.714 -74.006", 
        "HMS - Children's Hosp. Boston, Div. of Infectious Diseases": "42.358 -71.06", 
        "Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases": "33.836 -118.341", 
        "Incarnation Children's Ctr.": "40.714 -74.006", 
        "NYU Med. Ctr., Dept. of Medicine": "40.714 -74.006", 
        "St. Christopher's Hosp. for Children": "39.952 -75.164", 
        "St. Joseph's Hosp. & Med. Ctr. of New Jersey": "40.917 -74.172", 
        "Tulane/LSU Maternal/Child CRS": "29.951 -90.072", 
        "UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS": "34.052 -118.244", 
        "UCSD Maternal, Child, and Adolescent HIV CRS": "32.715 -117.157", 
        "UW School of Medicine - CHRMC": "47.606 -122.332", 
        "Univ. of Colorado Denver NICHD CRS": "39.729 -104.832", 
        "Univ. of Miami Ped. Perinatal HIV/AIDS CRS": "25.789 -80.226", 
        "Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS": "18.466 -66.106", 
        "Usc La Nichd Crs": "34.052 -118.244"
    }
}